ResMed CEO Michael J. Farrell disposes of common shares worth $1,110,188.53
RMD•Insider share sale and option exercise
- ResMed Chairman and CEO Michael J. Farrell sold 4,991 shares on Sept. 8, 2026 at an average price of USD 222.44.
- The sale followed the exercise of 4,991 stock options at USD 146.34.
- Direct holdings stood at 466,256 shares after the transactions.




